It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Collectively, rare genetic diseases affect a significant number of individuals worldwide. In this study, we have conducted whole-exome sequencing (WES) and identified underlying pathogenic or likely pathogenic variants in five children with rare genetic diseases. We present evidence for disease-causing autosomal recessive variants in a range of disease-associated genes such as DHH-associated 46,XY gonadal dysgenesis (GD) or 46,XY sex reversal 7, GNPTAB-associated mucolipidosis II alpha/beta (ML II), BBS1-associated Bardet–Biedl Syndrome (BBS), SURF1-associated Leigh Syndrome (LS) and AP4B1-associated spastic paraplegia-47 (SPG47) in unrelated affected members from Bangladesh. Our analysis pipeline detected three homozygous mutations, including a novel c. 863 G > C (p.Pro288Arg) variant in DHH, and two compound heterozygous variants, including two novel variants: c.2972dupT (p.Met991Ilefs*) in GNPTAB and c.229 G > C (p.Gly77Arg) in SURF1. All mutations were validated by Sanger sequencing. Collectively, this study adds to the genetic heterogeneity of rare genetic diseases and is the first report elucidating the genetic profile of (consanguineous and nonconsanguineous) rare genetic diseases in the Bangladesh population.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Genetics and Genomic Medicine Centre, NeuroGen Children’s Healthcare, Dhaka, Bangladesh; University of Dhaka, Department of Biochemistry and Molecular Biology, Dhaka, Bangladesh (GRID:grid.8198.8) (ISNI:0000 0001 1498 6059)
2 University of Dhaka, Department of Genetic Engineering & Biotechnology, Dhaka, Bangladesh (GRID:grid.8198.8) (ISNI:0000 0001 1498 6059)
3 Genetics and Genomic Medicine Centre, NeuroGen Children’s Healthcare, Dhaka, Bangladesh (GRID:grid.8198.8)
4 Mohammed Bin Rashid University of Medicine and Health Science, College of Medicine, Dubai, UAE (GRID:grid.8198.8)
5 BioTED, Dhaka, Bangladesh (GRID:grid.8198.8)
6 Genetics and Genomic Medicine Centre, NeuroGen Children’s Healthcare, Dhaka, Bangladesh (GRID:grid.8198.8); NeuroGen Children’s Healthcare, Department of Child Neurology, Dhaka, Bangladesh (GRID:grid.8198.8)
7 Bangabandhu Sheikh Mujib Medical University, Department of Endocrinology & Metabolism, Dhaka, Bangladesh (GRID:grid.411509.8) (ISNI:0000 0001 2034 9320)
8 Harvard Medical School, Department of Genetics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
9 The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); Newcastle University, Translational and Clinical Research Institute, Newcastle upon Tyne, UK (GRID:grid.1006.7) (ISNI:0000 0001 0462 7212)
10 The Hospital for Sick Children, Genome Diagnostics, Department of Pediatric Laboratory Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
11 Memorial University, Faculty of Medicine, St. John’s, Canada (GRID:grid.25055.37) (ISNI:0000 0000 9130 6822)
12 Mohammed Bin Rashid University of Medicine and Health Science, College of Medicine, Dubai, UAE (GRID:grid.25055.37)
13 University of Dhaka, Department of Biochemistry and Molecular Biology, Dhaka, Bangladesh (GRID:grid.8198.8) (ISNI:0000 0001 1498 6059)
14 The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, McLaughlin Centre and Department of Molecular Genetics, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
15 Mohammed Bin Rashid University of Medicine and Health Science, College of Medicine, Dubai, UAE (GRID:grid.17063.33)